Page |1
NUR166 EXAM 1 HONDROS 2025/2026 /NUR 166 EXAM 1
CONCEPTS OF FAMILY CENTERED NURSING FOR THE
PRACTICAL NURSING NEWEST 2025/2026 NEWEST ACTUAL
EXAM WITH COMPLETE QUESTIONS AND VERIFIED
ANSWERS |ALREADY GRADED A+|
The physiologic changes that normally occur in the older adult
have which implication for drug response in this patient?
A. Drug metabolism is faster.
B. Drug half-life is lengthened.
C. Drug elimination is faster.
D. Protein binding is more efficient. - ANSWER-B. Drug half-life is
lengthened.
Drug half-life is extended secondary to diminished liver and renal
function in the elderly.
When calculating pediatric dosages, what will the nurse take into
consideration?
, Page |2
A. Utilization of drug reference recommendations based on mg/kg
of body weight is the preferred method.
B. Calculated doses based on body weight need to be increased
by 10% due to immature renal and hepatic function.
C. Dosage calculation according to body weight is the most
accurate method because it takes into account differences in
maturational development.
D. Dosage calculation by body surface area is the most accurate
method because it takes into account the difference in size of the
child and/or neonate. - ANSWER-D. Dosage calculation by body
surface area is the most accurate method because it takes into
account the difference in size of the child and/or neonate.
The body surface area takes into account not only the child's
weight but also the relationship with height and is therefore both
the most accurate and most preferred method. Immature renal
and hepatic function would necessitate a decrease in dose, not an
increase.
What is the nurse's role in the development of new and
investigational drugs?
, Page |3
A. Monitoring for and reporting any adverse effects noted during
Phase IV studies
B. Selecting patients to participate in Phase I studies
C. Identifying patients who are receiving placebo drugs during
Phase III studies
D. Informing patients of the specific drug they are receiving within
a blinded investigational study during Phase III - ANSWER-A.
Monitoring for and reporting any adverse effects noted during
Phase IV studies
Phase IV studies rely on health care professionals to report
adverse effects that may not have been apparent in previous
phases. In most studies, neither the health care providers nor the
patients know which patients are being given the real drug versus
the placebo.
A pharmaceutical company is voluntarily conducting a
postmarketing study to obtain further proof of the therapeutic
effects of a new drug. What phase of drug study is this
considered?
, Page |4
A. Phase I
B. Phase II
C. Phase III
D. Phase IV - ANSWER-D. Phase IV
Phase IV studies are conducted by pharmaceutical companies
after the drug is on the market to obtain further data and
information on the drug.
New drugs must go through extensive research and testing before
approval for use in humans. The nurse is providing education to a
patient on a new medication and will inform the patient that the
average length of time a medication is researched before being
prescribed for humans is
A. 2 to 4 years.
B. 6 to 8 years.
C. 10 to 12 years.
D. 14 to 16 years. - ANSWER-C. 10 to 12 years.
NUR166 EXAM 1 HONDROS 2025/2026 /NUR 166 EXAM 1
CONCEPTS OF FAMILY CENTERED NURSING FOR THE
PRACTICAL NURSING NEWEST 2025/2026 NEWEST ACTUAL
EXAM WITH COMPLETE QUESTIONS AND VERIFIED
ANSWERS |ALREADY GRADED A+|
The physiologic changes that normally occur in the older adult
have which implication for drug response in this patient?
A. Drug metabolism is faster.
B. Drug half-life is lengthened.
C. Drug elimination is faster.
D. Protein binding is more efficient. - ANSWER-B. Drug half-life is
lengthened.
Drug half-life is extended secondary to diminished liver and renal
function in the elderly.
When calculating pediatric dosages, what will the nurse take into
consideration?
, Page |2
A. Utilization of drug reference recommendations based on mg/kg
of body weight is the preferred method.
B. Calculated doses based on body weight need to be increased
by 10% due to immature renal and hepatic function.
C. Dosage calculation according to body weight is the most
accurate method because it takes into account differences in
maturational development.
D. Dosage calculation by body surface area is the most accurate
method because it takes into account the difference in size of the
child and/or neonate. - ANSWER-D. Dosage calculation by body
surface area is the most accurate method because it takes into
account the difference in size of the child and/or neonate.
The body surface area takes into account not only the child's
weight but also the relationship with height and is therefore both
the most accurate and most preferred method. Immature renal
and hepatic function would necessitate a decrease in dose, not an
increase.
What is the nurse's role in the development of new and
investigational drugs?
, Page |3
A. Monitoring for and reporting any adverse effects noted during
Phase IV studies
B. Selecting patients to participate in Phase I studies
C. Identifying patients who are receiving placebo drugs during
Phase III studies
D. Informing patients of the specific drug they are receiving within
a blinded investigational study during Phase III - ANSWER-A.
Monitoring for and reporting any adverse effects noted during
Phase IV studies
Phase IV studies rely on health care professionals to report
adverse effects that may not have been apparent in previous
phases. In most studies, neither the health care providers nor the
patients know which patients are being given the real drug versus
the placebo.
A pharmaceutical company is voluntarily conducting a
postmarketing study to obtain further proof of the therapeutic
effects of a new drug. What phase of drug study is this
considered?
, Page |4
A. Phase I
B. Phase II
C. Phase III
D. Phase IV - ANSWER-D. Phase IV
Phase IV studies are conducted by pharmaceutical companies
after the drug is on the market to obtain further data and
information on the drug.
New drugs must go through extensive research and testing before
approval for use in humans. The nurse is providing education to a
patient on a new medication and will inform the patient that the
average length of time a medication is researched before being
prescribed for humans is
A. 2 to 4 years.
B. 6 to 8 years.
C. 10 to 12 years.
D. 14 to 16 years. - ANSWER-C. 10 to 12 years.
